Kamada (KMDA) Common Equity (2012 - 2026)

Kamada (KMDA) posted quarterly Common Equity of $259.4 million for Q1 2026, up 2.95% year-on-year from $252.0 million in Q1 2025, and down 3.6% on a QoQ basis from $269.1 million in Q4 2025.

Kamada (KMDA) Common Equity (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Common Equity for 15 consecutive years, with $259.4 million the latest figure, recorded in Q1 2026.

  • Quarterly Common Equity rose 2.95% year-over-year to $259.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $259.4 million (up 2.95% YoY) and the FY2025 annual result came in at $269.1 million, up 3.7% from the prior year.
  • Common Equity retreated to $259.4 million in Q1 2026 per KMDA's latest filing, from $269.1 million in the prior quarter.
  • Over the last five years, Common Equity for KMDA reached as high as $269.1 million in Q4 2025 and fell as low as $171574.0 in Q2 2022.
  • A 5-year average of $206.4 million and a median of $251.2 million in 2024 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2022 — Common Equity sank 99.91% — and 2023, when it jumped 138056.26%.
  • Year by year, Common Equity stood at $176.0 million in 2022, then soared by 38.63% to $244.0 million in 2023, then rose by 6.33% to $259.5 million in 2024, then gained by 3.7% to $269.1 million in 2025, then retreated by 3.6% to $259.4 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $259.4 million, $269.1 million, and $265.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.93 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 8.23 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 3.23 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 47.38 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.90 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 56.13 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 3.41 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.50 Bn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 259.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 259.39 Mn
Dec 31, 2025 269.07 Mn
Sep 30, 2025 265.23 Mn
Jun 30, 2025 259.95 Mn
Mar 31, 2025 251.96 Mn
Dec 31, 2024 259.46 Mn
Sep 30, 2024 255.27 Mn
Jun 30, 2024 251.15 Mn
Mar 31, 2024 251.15 Mn
Dec 31, 2023 244.02 Mn
Sep 30, 2023 238.39 Mn
Jun 30, 2023 176.75 Mn
Mar 31, 2023 174.81 Mn
Dec 31, 2022 176.02 Mn
Sep 30, 2022 172,551.00
Jun 30, 2022 171,574.00
Mar 31, 2022 175.15 Mn
Dec 31, 2021 176.82 Mn
Sep 30, 2021 181.61 Mn
Jun 30, 2021 182.34 Mn